• Latest Posts

M&As: what’s up with the ADC buying spree?

In Depth 13 Oct 2023

How close are we to a cure for metastatic breast cancer?

Epsilogen completes first clinical trial of IgE antibody to treat cancer

In Depth 26 Jul 2023

Antibody drug conjugates: BiVictriX drives a new era in cancer medicine

Podcast 7 Jul 2023

Beyond Biotech podcast 53: Antibody-drug conjugates


Lonza boosts ADC portfolio with Synaffix acquisition

ADC firm Adcentrx Therapeutics aims for clinic after $38M boost

FDA approves Genentech’s lymphoma drug

TORL BioTherapeutics launches with $158M to target cancer

BioNTech adds antibody-drug conjugates to cancer portfolio with potential $1.5B partnership deal

Podcast 31 Mar 2023

Beyond Biotech podcast 40: Antibody-drug conjugates